Zoeken
login
home
contact
search
print
School for Cardiovascular Diseases
about CARIM
background
organization
annual report
visit CARIM
logo and branding
links
research
principal Investigators (PI's)
research clusters
theses
CARIM Theses 2012
CARIM Theses 2011
publications
CARIM people
education
PhD training program
Research Master
Physician-Clinical Investigator program
I'MCARIM
CARIM Lectures
working@carim
vacancies
scientific staff
PhD positions
technical staff
other vacancies
living in Maastricht
news & events
news
events
archive
research
CARIM people
foto
Coen Stehouwer
position
prof. dr.
function
Principal Investigators
email
cda.stehouwer@mumc.nl
phone secr.
+31 (0)43 3877006
department
Internal Medicine
publications
published on 14-09-2010
Arterial calcifications
published on 23-07-2010
Inhibition of thrombin formation by active site mutated (S360A) activated protein C
published on 01-09-2010
Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability as determined by thrombin generation in plasma: the role of central obesity and low-grade inflammation. The Hoorn Study
published on 01-12-2010
Body composition as determinant of thrombin generation in plasma: the Hoorn study
published on 01-12-2010
Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus
published on 01-08-2010
Angiotensin II enhances insulin-stimulated whole-body glucose disposal but impairs insulin-induced capillary recruitment in healthy volunteers
published on 01-10-2010
Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity-but not a PCOS-associated phenomenon
published on 01-04-2010
Distinct ethnic differences in lipid profiles across glucose categories
published on 01-05-2010
Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress
published on 01-05-2010
Irbesartan treatment does not influence plasma levels of the advanced glycation end products CML and CEL in patients with type 2 diabetes and microalbuminuria. An IRMA2 substudy
1
2
3
next
return to Carim people
@errormessage@
privacy:
Extranet
Extranet en gedeeltelijk website
Extranet en website(geheel)
lastname: *
middlename:
firstname: *
initials:
position: *
function:
- select function -
@function_name@
birthday:
email: *
password: *
password (re-enter): *
phone:
phone 2:
mobile:
phone secr.:
linkedIn:
website:
office:
department:
- select department -
@department_name@
room number:
programs:
@programme_titel@
Cancel